He Liang Fu
Chairman chez JIANGSU AIDEA PHARMACEUTICAL CO., LTD.
Fortune : 3 M $ au 31/03/2024
Profil
He Liang Fu is currently the Chairman at Jiangsu Aidea Pharmaceutical Co., Ltd.
He previously held the position of President at Techpool Bio-Pharma Co., Ltd.
and was a Professor at Sun Yat-Sen University.
He obtained his undergraduate degree from Nanjing University in 1989.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/08/2022 | 721 283 ( 0,33% ) | 2 M $ | 31/03/2024 | |
| 29/12/2022 | 1 167 600 ( 0,23% ) | 2 M $ | 31/03/2024 |
Postes actifs de He Liang Fu
| Sociétés | Poste | Début |
|---|---|---|
| JIANGSU AIDEA PHARMACEUTICAL CO., LTD. | Chairman | 01/01/2014 |
Anciens postes connus de He Liang Fu
| Sociétés | Poste | Fin |
|---|---|---|
| Sun Yat-Sen University | Corporate Officer/Principal | - |
Techpool Bio-Pharma Co., Ltd.
 Techpool Bio-Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Techpool Bio-Pharma Co., Ltd. researches, develops, manufactures, and markets bio-pharmaceutical products. Its products include Techpool Roan, Kailikang, Bondronat and Roxin. The firm specializes in the sales, research and development, and production of biopharmaceuticals in critical care. The company was founded in 1993 and is headquartered in Guangzhou, China. | President | - |
Formation de He Liang Fu
| Nanjing University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JIANGSU AIDEA PHARMACEUTICAL CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Techpool Bio-Pharma Co., Ltd.
Techpool Bio-Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Techpool Bio-Pharma Co., Ltd. researches, develops, manufactures, and markets bio-pharmaceutical products. Its products include Techpool Roan, Kailikang, Bondronat and Roxin. The firm specializes in the sales, research and development, and production of biopharmaceuticals in critical care. The company was founded in 1993 and is headquartered in Guangzhou, China. | Health Technology |
